Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 5352Session 2025-2026

Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product

S5352

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content

New York State Assembly

Speaker Carl E. Heastie

  • Assembly Members
  • Legislative Info
  • Public Hearings
  • Speaker's Press
  • Assembly Reports
  • Committees & More
  • Bill Search Home
  • Laws
  • Legislative Calendar
  • Public Hearing Schedule
  • Assembly Calendars
  • Assembly Committee Agenda
Javascript must be enabled to properly view this page. Bill No.:  
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee&nbspVotes 
  •  
  •  Floor&nbspVotes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber&nbspVideo/Transcript 

S05352 Summary:

BILL NOS05352
 
SAME ASNo Same As
 
SPONSORCOMRIE
 
COSPNSR
 
MLTSPNSR
 
Amd ?6810, Ed L
 
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
Go to top

S05352 Text:

STATE OF NEW YORK ________________________________________________________________________ 5352 2025-2026 Regular Sessions IN SENATE February 20, 2025 ___________ Introduced by Sen. COMRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 6 of section 6810 of the education law is 2 amended by adding a new paragraph (b-1) to read as follows: 3 (b-1) The prescriber or pharmacist shall inform the patient whether 4 they have prescribed or substituted a different generic drug product 5 from the generic drug product the patient has previously received. 6 Notification required pursuant to this paragraph shall be provided both 7 written and orally. 8 § 2. This act shall take effect on the ninetieth day after it shall 9 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09499-01-5 Go to top <link href="/styles/noscript_styles.css" rel="stylesheet"/> Sitemap Request Information Directions and Maps

Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.